Asia

123
  • 文章类型: Journal Article
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    高血压仍然是世界范围内的主要问题,尤其是整个亚太地区,报告患病率高,治疗率和血压(BP)控制率改善缓慢。亚洲高血压患者在表型和高血压并发症的流行病学方面也可能有所不同,尤其是与西方患者相比。鉴于这些差异,西方准则不一定适用于亚太地区的国家。这篇叙述性综述旨在对最近发布的欧洲高血压学会(ESH)2023年指南与部分亚洲国家的现有当地指南进行批判性比较。就如何填补ESH2023亚洲高血压指南中的空白提供专家意见,并研究在全球范围内统一高血压指南的必要性。本文就高血压的定义和诊断进行综述,治疗阈值和目标,以及使用药物治疗的建议。
    Hypertension remains a major problem worldwide, especially across the Asia-Pacific region, which reports high prevalence rates and slow improvements in treatment rate and blood pressure (BP) control rate. Asian patients with hypertension may also vary with regard to phenotype and the epidemiology of the complications of hypertension, especially when compared with Western patients. Given these differences, Western guidelines may not necessarily be applicable to countries in the Asia Pacific. This narrative review aims to provide a critical comparison between the recently published European Society of Hypertension (ESH) 2023 guidelines and existing local guidelines in select Asian countries, offer expert opinion on how to fill gaps in the ESH 2023 guidelines for hypertension in the Asian context, and examine the need for harmonisation of hypertension guidelines worldwide. This review focuses on the definition and diagnosis of hypertension, the treatment thresholds and targets, and recommendations on the use of pharmacotherapy.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: English Abstract
    具有坚实策略的临床试验对于改善罕见儿童白血病的结局是必不可少的,例如婴儿急性淋巴细胞白血病(ALL)和与唐氏综合征相关的ALL。国际合作有助于试验成功。我是与亚洲国家合作进行与唐氏综合症相关的ALL国际试验的小组的成员。虽然我们达到了招生目标,日本以外没有注册。我们还计划了一项针对无法分类的急性白血病的临床试验,但由于对治疗方案的选择缺乏共识,因此放弃了这项努力.许多因素必须结合在一起,国际审判才能成功,不仅包括研究的概念,主题,和目标,还有组织,物流,and,最终,训练有素的专业人员来执行它。同时,当然,需要适当的时机和运气。不同文化国家的国际试验,社会组织,和医疗系统需要坚持不懈的努力和谈判技巧。专业培训和基础设施发展是实现这一目标的必要条件。
    Clinical trials with a solid strategy are indispensable for improving outcomes of rare childhood leukemias such as infant acute lymphoblastic leukemia (ALL) and ALL associated with Down syndrome, and international collaboration contributes to trial success. I am part of a group conducting an international trial of ALL associated with Down syndrome in collaboration with Asian countries. Although we are meeting enrollment targets, there have been no enrollments outside Japan. We also planned a clinical trial in unclassifiable acute leukemia, but abandoned this effort due to a lack of consensus on the choice of treatment regimen. Many elements must fit together for an international trial to succeed, including not only the study\'s concept, theme, and objectives, but also the organization, the logistics, and, ultimately, trained professionals to carry it out. At the same time, of course, there is the need for appropriate timing and luck. International trials across countries with different cultures, social organizations, and medical systems require persistent effort and negotiation skills. Professional training and infrastructure development are necessary to make this possible.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    这项研究探讨了生态位保守主义(NC)的概念及其对大黄蜂(膜翅目:Vespidae)和蜜蜂如何应对气候变化的影响。我们的主要目标有三个:首先,评估亚洲12只大黄蜂和蜜蜂之间是否存在不同的环境生态位空间(E-space),如Apiscerana和Apismellifera;其次,探索亚洲大黄蜂与蜜蜂物种达到地理平衡的程度。最后,是调查在气候变化情景下,大黄蜂和蜜蜂之间的地理生态位重叠(G空间)可能如何变化。为了实现这些目标,我们采用了排序和生态位建模技术来分析地理(G空间)和环境(E空间)环境中的91对大黄蜂和蜜蜂。然后,我们预测了气候变化对大黄蜂和蜜蜂之间未来地理重叠的潜在影响,特别是在2070年的SSP585气候情景下。我们的结果表明,大黄蜂和蜜蜂的环境生态位(E空间)可以被视为可互换的,表明尽管它们是不相关的分类单元,但它们具有相似的环境偏好。我们发现,Vespavelutina目前与两种蜜蜂都表现出0.63的适度地理生态位重叠(G空间)。同时,Vespamandarinia与Apiscerana重叠0.46,与Apismellifera重叠0.63。与Apismellifera相比,Vespavelutina与Apiscerana的重叠可能会减少到0.51和0.56。对于VespaMandarinia来说,在气候变化情景下,与Apiscerana的重叠可能达到0.41,与Apismellifera的重叠可能达到0.6。这项研究表明,亚洲某些地区蜜蜂和大黄蜂之间有限的空间重叠更可能受到地理障碍的影响,而不仅仅是环境对大黄蜂的不适合性。在这项研究中,我们深入研究了生态位保守主义(NC)的概念及其对大黄蜂(膜翅目:Vespidae)和蜜蜂如何应对气候变化的影响。
    This study delves into the concept of niche conservatism (NC) and its implications for how hornets (Hymenoptera: Vespidae) and honeybees respond to climate change. Our primary objectives are threefold: firstly, to assess whether distinct environmental niche spaces (E-space) exist between 12 hornets and honeybees like Apis cerana and Apis mellifera in Asia; Secondly, to explore the degree to which Asian hornets have attained geographic equilibrium alongside honeybee species. Lastly, is to investigate how the geographic niche overlap (G-space) between hornets and honeybees could potentially change under climate change scenarios. To accomplish these goals, we employed ordination and ecological niche modeling techniques to analyze 91 pairs of hornets and honeybees in both geographic (G-space) and environmental (E-space) contexts. Then, we projected the potential impacts of climate change on the future geographic overlap between hornets and honeybees, specifically under the SSP585 climate scenario for the year 2070. Our results demonstrated that the environmental niches (E-space) of hornets and honeybees can be treated as interchangeable, indicating they have similar environmental preferences despite being unrelated taxa. We found that Vespa velutina currently exhibits a moderate geographic niche overlap (G-space) of 0.63 with both honeybee species. Meanwhile, Vespa mandarinia demonstrates an overlap of 0.46 with Apis cerana and 0.63 with Apis mellifera. The overlap of Vespa velutina with Apis cerana might potentially decrease to 0.51 and 0.56 with Apis mellifera. For Vespa mandarinia, the overlap could reach 0.41 with Apis cerana and 0.6 with Apis mellifera under a climate change scenario. This study indicates that the limited spatial overlap between honeybees and hornets across certain areas in Asia is more likely influenced by geographical barriers rather than solely environmental unsuitability for hornets. In this study, we delve into the concept of niche conservatism (NC) and its implications for how hornets (Hymenoptera: Vespidae) and honeybees respond to climate change.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:弓形虫可在免疫缺陷宿主中引起症状性弓形虫病,包括患有人类免疫缺陷病毒(PLWH)的人,主要是因为潜伏感染的重新激活。我们使用国际流行病学数据库(IEDEA)亚太地区的TREATAsia人类免疫缺陷病毒(HIV)观察数据库(TAHOD)的数据评估了亚太地区PLWH中弓形虫病的患病率及其相关危险因素。
    方法:本研究包括1997年至2020年报告的回顾性和前瞻性弓形虫病病例。采用匹配的病例对照方法,其中诊断为弓形虫病的PLWH(病例)分别与来自同一部位的两个无弓形虫病诊断的PLWH(对照)相匹配。没有弓形虫病的部位被排除。使用条件逻辑回归分析弓形虫病的危险因素。
    结果:共有269/9576(2.8%)PLWH在19个TAHOD部位被诊断为弓形虫病。其中,227例(84%)回顾性报道,42例(16%)是队列登记后的前瞻性诊断。在弓形虫病诊断时,中位年龄为33岁(四分位距28-38),80%的参与者是男性,75%的患者没有接受抗逆转录病毒治疗(ART)。在269个没有CD4值的人中,包括63个,192例(93.2%)CD4≤200细胞/μL,162例(78.6%)CD4≤100细胞/μL。通过使用538个匹配的控件,我们发现与弓形虫病相关的因素包括戒除ART(比值比[OR]3.62,95%CI1.81-7.24),与接受核苷逆转录酶抑制剂加非核苷逆转录酶抑制剂相比,通过注射药物接触HIV(OR2.27,95%CI1.15-4.47),而不是进行异性性交和乙型肝炎病毒表面抗原检测呈阳性(OR3.19,95%CI1.41-7.21)。随着CD4计数的增加,弓形虫病的可能性较小(51-100细胞/μL:OR0.41,95%CI0.18-0.96;101-200细胞/μL:OR0.14,95%CI0.06-0.34;>200细胞/μL:OR0.02,95%CI0.01-0.06),当与CD4≤50细胞/μL相比时。此外,预防性使用复方新诺明与弓形虫病无关.
    结论:症状性弓形虫病很少见,但在亚太地区的PLWH中仍然存在,特别是在延迟诊断的情况下,导致晚期HIV疾病。通过早期诊断和ART管理的免疫重建仍然是亚洲PLWH的优先事项。
    BACKGROUND: Toxoplasma gondii can cause symptomatic toxoplasmosis in immunodeficient hosts, including in people living with human immunodeficiency virus (PLWH), mainly because of the reactivation of latent infection. We assessed the prevalence of toxoplasmosis and its associated risk factors in PLWH in the Asia-Pacific region using data from the TREAT Asia Human Immunodeficiency Virus (HIV) Observational Database (TAHOD) of the International Epidemiology Databases to Evaluate AIDS (IeDEA) Asia-Pacific.
    METHODS: This study included both retrospective and prospective cases of toxoplasmosis reported between 1997 and 2020. A matched case-control method was employed, where PLWH diagnosed with toxoplasmosis (cases) were each matched to two PLWH without a toxoplasmosis diagnosis (controls) from the same site. Sites without toxoplasmosis were excluded. Risk factors for toxoplasmosis were analyzed using conditional logistic regression.
    RESULTS: A total of 269/9576 (2.8%) PLWH were diagnosed with toxoplasmosis in 19 TAHOD sites. Of these, 227 (84%) were reported retrospectively and 42 (16%) were prospective diagnoses after cohort enrollment. At the time of toxoplasmosis diagnosis, the median age was 33 years (interquartile range 28-38), and 80% participants were male, 75% were not on antiretroviral therapy (ART). Excluding 63 out of 269 people without CD4 values, 192 (93.2%) had CD4 ≤200 cells/μL and 162 (78.6%) had CD4 ≤100 cells/μL. By employing 538 matched controls, we found that factors associated with toxoplasmosis included abstaining from ART (odds ratio [OR] 3.62, 95% CI 1.81-7.24), in comparison to receiving nucleoside reverse transcriptase inhibitors plus non-nucleoside reverse transcriptase inhibitors, HIV exposure through injection drug use (OR 2.27, 95% CI 1.15-4.47) as opposed to engaging in heterosexual intercourse and testing positive for hepatitis B virus surface antigen (OR 3.19, 95% CI 1.41-7.21). Toxoplasmosis was less likely with increasing CD4 counts (51-100 cells/μL: OR 0.41, 95% CI 0.18-0.96; 101-200 cells/μL: OR 0.14, 95% CI 0.06-0.34; >200 cells/μL: OR 0.02, 95% CI 0.01-0.06), when compared to CD4 ≤50 cells/μL. Moreover, the use of prophylactic cotrimoxazole was not associated with toxoplasmosis.
    CONCLUSIONS: Symptomatic toxoplasmosis is rare but still occurs in PLWH in the Asia-Pacific region, especially in the context of delayed diagnosis, causing advanced HIV disease. Immune reconstitution through early diagnosis and ART administration remains a priority in Asian PLWH.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    这项研究的目的是对30年(1991年至2021年)的风湿性心脏病(RHD)疾病负担趋势进行时间分析。专注于患病率,死亡,和南亚(SA)的残疾调整寿命年(DALYs)。
    在这项生态研究中,我们分析了SA地区1991年至2021年的全球疾病负担(GBD)研究中有关RHD负担的数据.RHD相关患病率的估计,死亡,和DALYs以及每100,000人口的年龄标准化率(ASR)和95%不确定度区间(UI)进行了评估。
    2021年RHD的总体流行病例为54785.1×103(43328.4×103至67605.5×103),其中14378.8×103(11206.9×103至18056.9×103)来自SA。在1991年至2021年之间,点患病率的ASR呈上升趋势,在全球范围内,SA的年平均百分比变化(AAPC)为0.40(0.39至0.40)和0.12(0.11至0.13),分别。2021年与RHD相关的死亡总数为373.3×103(324.1×103至444.8×103),其中215×103(176.9×103至287.8×103)来自SA,占全球死亡人数的57.6%。在1991年至2021年之间,死亡的ASR也呈下降趋势,在全球范围内,SA的AAPC为-2.66(-2.70至-2.63)和-2.07(-2.14至-2.00),分别。DALYs的ASR在1990年至2019年期间显示出下降趋势,在全球水平和南亚区域,AAPC为-2.47(-2.49至-2.44)和-2.22(-2.27至-2.17),分别。
    RHD的年龄标准化患病率上升仍然是全球关注的问题,特别是在南亚,占全球RHD相关死亡人数的50%以上。令人鼓舞的是,与RHD相关的死亡和DALYs的下降趋势暗示了全球和区域范围内RHD管理和治疗的进展。
    UNASSIGNED: The objective of this study is to conduct a temporal analysis of rheumatic heart disease (RHD) disease burden trends over a 30-year period (1991 to 2021), focusing on prevalence, deaths, and disability-adjusted life years (DALYs) in the South Asia (SA).
    UNASSIGNED: In this ecological study, we analyzed data regarding burden of RHD from the Global Burden of Diseases (GBD) study spanning the years 1991 to 2021 for the SA Region. Estimates of the number RHD-related prevalence, deaths, and DALYs along with age-standardized rates (ASR) per 100,000 population and 95% uncertainty intervals (UI) were evaluated.
    UNASSIGNED: The overall prevalent cases of RHD in the 2021 were 54785.1 × 103 (43328.4 × 103 to 67605.5 × 103), out of which 14378.8 × 103 (11206.9 × 103 to 18056.9 × 103) were from SA. The ASR of point prevalence showed upward trend between 1991 and 2021, at global level and for SA with an average annual percentage change (AAPC) of 0.40 (0.39 to 0.40) and 0.12 (0.11 to 0.13), respectively. The overall number of RHD-related deaths in the 2021 were 373.3 × 103 (324.1 × 103 to 444.8 × 103), out of which 215 × 103 (176.9 × 103 to 287.8 × 103) were from SA, representing 57.6% of the global deaths. The ASR of deaths also showed downward trend between 1991 and 2021, at global level and for SA with an AAPC of -2.66 (-2.70 to -2.63) and -2.07 (-2.14 to -2.00), respectively. The ASR of DALYs showed downward trend between 1990 and 2019, at global level and for South Asian region with an AAPC of -2.47 (-2.49 to -2.44) and -2.22 (-2.27 to -2.17), respectively.
    UNASSIGNED: The rising age-standardized prevalence of RHD remains a global concern, especially in South Asia which contribute to over 50% of global RHD-related deaths. Encouragingly, declining trends in RHD-related deaths and DALYs hint at progress in RHD management and treatment on both a global and regional scale.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    随着越来越多的放射科医生变得具有AI知识,人工智能(AI)在放射学领域迅速获得认可。然而,人工智能解决方案在临床环境中的采用和实施进展缓慢,有争论点。一群人工智能用户,主要由亚洲各个国家的临床放射科医生组成,包括印度,Japan,马来西亚,新加坡,台湾,泰国,乌兹别克斯坦,成立了工作组。这项研究旨在起草有关AI在放射学中的应用和临床部署的立场声明。主要目的是提高公众的认识,促进专业兴趣和讨论,澄清实施人工智能技术时的道德考虑,并在不断变化的临床实践中从事放射学专业。这些立场声明强调了护理提供者和护理接受者之间需要解决的相关问题。更重要的是,这将有助于在临床部署中合法使用非人器械,而不会损害道德考虑,决策精度,和临床专业标准。我们的研究基于医疗护理的四个主要原则-尊重患者自主权,仁慈,非恶意,和正义。
    Artificial intelligence (AI) is rapidly gaining recognition in the radiology domain as a greater number of radiologists are becoming AI-literate. However, the adoption and implementation of AI solutions in clinical settings have been slow, with points of contention. A group of AI users comprising mainly clinical radiologists across various Asian countries, including India, Japan, Malaysia, Singapore, Taiwan, Thailand, and Uzbekistan, formed the working group. This study aimed to draft position statements regarding the application and clinical deployment of AI in radiology. The primary aim is to raise awareness among the general public, promote professional interest and discussion, clarify ethical considerations when implementing AI technology, and engage the radiology profession in the ever-changing clinical practice. These position statements highlight pertinent issues that need to be addressed between care providers and care recipients. More importantly, this will help legalize the use of non-human instruments in clinical deployment without compromising ethical considerations, decision-making precision, and clinical professional standards. We base our study on four main principles of medical care-respect for patient autonomy, beneficence, non-maleficence, and justice.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Editorial
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    水产养殖环境的监测和操作的进步已将养殖水产品中某些残留污染物的浓度降至最低。然而,目前大多数水产品都是“养殖”,螃蟹组织中残留污染物之间的关系尚不清楚。在这项研究中,64种典型污染物,包括25种抗生素,15金属,23种有机氯农药,并对一种二恶英样化合物诱导碳氢化合物受体(AHR)活性进行了评估和排名。组合评估了属性的叠加,包括描述持久性和暴露的影响和参数的严重程度和相对效力,以及最有可能暴露的群体的使用率和识别,以对饮食暴露的可能性和每种污染物的不利影响概率进行排名。结果表明,每种污染物的总分发现镉(Cd),七氯环氧化物(HEPE),二恶英TEQ表现出最高的分数,并解释了饮食风险的严重程度,而来源分析发现,这三种主要污染物来自周围环境,而不是由于特定的水产养殖过程。总之,环境仍然是中国养殖中华绒螯蟹残留污染物的主要来源。
    Advancements in monitoring and operation of aquaculture environments has minimized the concentrations of some residual pollutants in cultured aquatic products. However, currently most aquatic products are \"farmed\", and relationships among residual pollutants in tissues of crabs were still unclear. In this study, 64 typical pollutants, including 25 antibiotics, 15 metal, 23 organochlorine pesticides, and one dioxin-like compound inducing hydrocarbon-receptor (AHR) activity were measured in Chinese mitten crab (Eriocheir Sinensis) risks of consumption assessed and ranked. The superposition of properties including severity and relative potency of effects and parameters describing persistence and exposure along with rates of usage and identification of groups most likely to be exposed were assessed in combination to rank likelihood of dietary exposure and probabilities of adverse effects for each contaminant. The results indicated that the total scores per pollutants found that Cadmium (Cd), Heptachlor epoxide (HEPE), dioxin TEQ exhibited the greatest scores and explained the severity of dietary risk, while source analysis found that the three main pollutants resulted from the ambient environment and are not due to specific aquaculture processes. In summary, environment is still the predominant source of residual pollutants in cultured Chinese mitten crab across China.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    公众对政府能力的信任程度对于防止错误信息的传播和减少大流行期间的心理困扰至关重要。该研究旨在(i)探索对来自不同来源的COVID-19信息的信任以及对世界卫生组织(WHO)能力的信任,政府部门和相关机构在处理新加坡的流行病,以及(ii)其与新加坡居民中感知的感染风险的关联。
    在2020年5月至2021年6月期间,共有1,129名参与者(21岁及以上)从一项横断面研究中招募,检查新加坡人口的福祉和韧性。对来自不同来源的COVID-19信息的信任以10点量表和序数7点量表衡量感知的感染风险。采用描述性统计和多因素logistic回归模型。
    85.5%的人报告说,他们对政府提供的COVID-19信息及其处理大流行的能力有很高的信任。参与者还报告说,当地公共卫生或传染病专家(84.4%)和传统媒体(77.2%)对COVID-19信息的高度信任。对政府部门和相关机构能力的低信任与较高的未来(1个月)感知感染风险相关(OR:5.7,95%CI1.02-32.45),对社交媒体的低信任与较高的当前感知感染风险相关(OR:2.4,95%CI1.09-5.24)。
    本研究提供了对来自不同来源的COVID-19信息的信任水平及其相关的感染风险的见解。建议进行未来的定性研究,以促进对公众信任的更好理解,并确定如何有效解决该问题的策略,以支持未来的公共卫生对策。
    UNASSIGNED: The degree of public trust in the government\'s competence is crucial in preventing the spread of misinformation and reducing psychological distress during a pandemic. The study aimed to (i) explore the trust in COVID-19 information from different sources and trust in the ability of the World Health Organization (WHO), government departments and related institutions in handling the epidemic in Singapore and (ii) its association with perceived risk of infection among Singapore residents.
    UNASSIGNED: A total of 1,129 participants (aged 21 and above) were recruited from a cross-sectional study examining the well-being and resilience of Singapore\'s population between May 2020 to June 2021. Trust in COVID-19 information from different sources was measured on a 10-point scale and an ordinal 7-point scale was used for perceived risk of infection. Descriptive statistics and multivariate logistic regression model were conducted.
    UNASSIGNED: 85.5% reported high trust in COVID-19 information from the government and their ability in handling the pandemic. Participants also reported high trust in COVID-19 information from local public health or infectious disease experts (84.4%) and traditional media (77.2%). Low trust in the ability of government departments and related institutions was associated with higher future (1 month) perceived risk of infection (OR: 5.7, 95% CI 1.02-32.45) and low trust in social media was associated with higher current perceived risk of infection (OR: 2.4, 95% CI 1.09-5.24).
    UNASSIGNED: The present study provided insight on the level of trust on COVID-19 information from different sources and its associated perceived risks of infection. Future qualitative studies are recommended to facilitate better understanding of public trust and identify strategies for how it can be effectively addressed to support future public health responses.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号